Treating lung inflammation depends on what’s causing it, but the core approach combines medication to calm the immune response, lifestyle changes that lower inflammation over time, and structured rehabilitation when the condition is chronic. Lung inflammation isn’t a single disease. It’s a feature of asthma, COPD, pneumonia, COVID-19 recovery, and autoimmune conditions, so the right treatment path starts with identifying the underlying trigger.
What Happens During Lung Inflammation
When your lungs detect something harmful, whether it’s an infection, allergen, or irritant, your immune system launches a defense. White blood cells called neutrophils arrive first, flooding the airways and releasing chemicals that attack the threat but also damage surrounding tissue. Shortly after, a second wave of immune cells moves in and sustains the inflammatory response over a longer period. Two key signaling molecules drive this process early on: one that amplifies pain and swelling, and another produced by immune cells that has wide-ranging effects on how the body fights invaders.
In a healthy response, this inflammation resolves on its own once the threat is cleared. But when the trigger persists (chronic allergen exposure, ongoing smoking, an autoimmune process), the immune system never fully stands down. The result is tissue damage, scarring, and progressively worsening breathing. That distinction between acute and chronic inflammation shapes every treatment decision.
Inhaled Corticosteroids for Airway Inflammation
Inhaled corticosteroids are the backbone of treatment for conditions like asthma and COPD where inflammation is ongoing. These medications work by suppressing the immune signaling that keeps airways swollen and reactive. Because they’re inhaled directly into the lungs, they deliver anti-inflammatory effects right where they’re needed while minimizing the side effects that come with oral steroids.
The two most commonly prescribed are budesonide and fluticasone. Adults using budesonide typically inhale 360 micrograms twice a day, with a maximum of 720 micrograms twice daily. Children between 6 and 17 use a lower dose of 180 micrograms twice daily. Fluticasone comes in several formulations, with doses ranging from 50 micrograms for younger children to 100 or 200 micrograms for those 12 and older. Your doctor adjusts the dose based on how well your symptoms respond and how your lung function tests look over time.
These medications don’t provide instant relief during an attack. They work by gradually reducing the baseline level of inflammation in your airways over days to weeks of consistent use. Many people notice improvement within the first week, but it can take a month or more to reach full effect. Skipping doses or stopping early is one of the most common reasons treatment fails.
Oral Steroids for Flare-Ups
When inflammation spikes during an acute flare-up, whether from a respiratory infection, allergen exposure, or worsening COPD, a short course of oral corticosteroids is often necessary. These are far more potent than inhaled versions and work systemically to bring inflammation under control quickly. A typical course lasts five to seven days.
Not every flare-up benefits equally from oral steroids, though. One way doctors gauge whether steroids will help is by measuring exhaled nitric oxide, a marker of a specific type of airway inflammation. A reading at or above 50 parts per billion strongly supports using oral steroids. But when that reading is 20 ppb or lower, oral steroids may offer limited benefit, and other approaches like antibiotics (if infection is the trigger) become more appropriate. This test is simple and noninvasive: you breathe steadily into a handheld device for about 10 seconds.
Biologic Therapies for Severe Cases
For people with severe asthma or other chronic inflammatory lung conditions that don’t respond adequately to standard inhalers, biologic therapies represent a newer class of treatment. These are injectable medications, usually given every two to four weeks, that target specific molecules driving the inflammatory process.
The available biologics each block a different part of the inflammatory chain. Some target a molecule called IL-5, which fuels the production of eosinophils, a type of white blood cell that causes tissue damage in the airways. Others block the receptors for IL-4 and IL-13, two signaling molecules strongly linked to allergic-type inflammation. The newest option targets a molecule released by airway cells called TSLP, which sits even further upstream in the inflammatory cascade, potentially helping a broader range of patients.
Biologics can dramatically reduce flare-ups and steroid dependence, but they’re reserved for people whose inflammation is clearly driven by these specific pathways. Blood tests measuring eosinophil counts (typically needing to be above 400 cells per microliter for some biologics) and exhaled nitric oxide levels help determine which, if any, biologic is the right match.
Diet and Its Effect on Lung Inflammation
What you eat has a measurable effect on lung inflammation. Research from the National Institute on Minority Health and Health Disparities found that a healthy, anti-inflammatory diet was associated with better lung function even in people without asthma. High-fat and high-sugar diets promote inflammation, while high-fiber diets rich in vegetables, fruits, and whole grains help reduce it. Studies have also shown that higher intake of whole grains and lower intake of trans fats can improve asthma control specifically.
This doesn’t mean diet replaces medication. But for someone managing a chronic inflammatory lung condition, shifting toward a Mediterranean-style eating pattern (heavy on fruits, vegetables, legumes, fish, and olive oil) creates a less inflammatory environment throughout the body, including the lungs. The effect is gradual and cumulative rather than immediate, making it a complement to medical treatment rather than a substitute.
Pulmonary Rehabilitation
Pulmonary rehabilitation, a structured program combining supervised exercise, breathing techniques, and education, does more than improve fitness. It directly reduces inflammatory markers in people with COPD. A meta-analysis of randomized controlled trials published in the European Respiratory Journal found that programs lasting four weeks or longer significantly reduced levels of two key inflammatory markers: TNF-alpha and C-reactive protein (CRP). TNF-alpha is one of the primary molecules that sustains chronic lung inflammation, and CRP is a general marker of systemic inflammation.
The exercise component typically includes both aerobic training (walking, cycling) and resistance exercises, performed three to five times per week. The benefits extend well beyond inflammation reduction. People who complete pulmonary rehab consistently report less shortness of breath, better exercise tolerance, and improved quality of life. Most programs run six to twelve weeks, though continuing regular exercise afterward is essential for maintaining the gains.
Recovery Timelines After Acute Inflammation
If your lung inflammation was triggered by pneumonia or another acute infection, the infection itself may clear within a week or two of treatment, but the inflammation it caused lingers much longer than most people expect. Research published in Circulation Research found that pneumonia survivors continue to have elevated lung and systemic inflammation for at least four to six weeks after the infection has clinically resolved. The actual duration may be even longer, as studies haven’t followed this phenomenon further out.
This means feeling winded, fatigued, or having a lingering cough for weeks after pneumonia is normal and reflects ongoing inflammation rather than a new problem. Chest X-rays can remain abnormal for six to eight weeks in many cases, even when you’re improving. Recovery during this period benefits from gradual return to activity, adequate sleep, and good nutrition. Pushing too hard too soon doesn’t speed up the resolution of inflammation and can make symptoms worse.
Reducing Environmental Triggers
No medication works as well when the thing causing inflammation keeps entering your lungs. For smokers, quitting is the single most effective intervention for reducing chronic lung inflammation, more impactful than any drug. Within weeks of stopping, inflammatory markers begin to drop, and the rate of lung function decline slows substantially.
For non-smokers, common triggers include indoor air pollution (mold, dust mites, pet dander, volatile organic compounds from cleaning products), outdoor air pollution, and occupational exposures to dust, fumes, or chemicals. Using HEPA air purifiers, washing bedding in hot water weekly, keeping indoor humidity below 50% to discourage mold growth, and wearing appropriate respiratory protection at work all reduce the inflammatory load on your lungs. These changes won’t reverse existing damage, but they remove the ongoing provocation that keeps the immune response active.